BioSpace News Archive

Business

Takeda to Close Illinois Headquarters and Move Operations to Boston

Takeda Pharmaceuticals will shutter its Deerfield, Ill. U.S. headquarters and move the operations to Boston as the company consolidates its operations following the $62 billion acquisition of Shire.

September 12, 2018
·
3 min read
·
Alex Keown
Business

CODA Biotherapeutics Launches with $19 Million to Tackle Neuropathic Pain

CODA Biotherapeutics launched in South San Francisco with a $19 million Series A financing.

September 12, 2018
·
2 min read
·
Mark Terry
Biotech Bay

New Flu Season, New Flu Drug from Genentech

Last year’s influenza season in the U.S. had record-breaking hospitalization rates. A lot of industry observers are looking at a new flu drug, baloxavir marboxil, for which clinical trial data was just published.

September 12, 2018
·
3 min read
·
Mark Terry
Plasticell wins military contract to develop regenerative medicines for the battlefield.

Plasticell Ltd has announced that it has been contracted by the Ministry of Defence (MoD) in a pilot programme to develop regenerative medicines for the treatment of injuries resulting from combat or terrorism.

September 12, 2018
·
2 min read
Clinithink receives RARE Champion of Hope award for their ‘notable efforts’ in rare disease

Clinithink has been selected to receive the RARE Champion of Hope – Collaborations in Science and Technology award at the 7th Annual RARE Patient Advocacy Summit on October 4th in Irvine, California.

September 12, 2018
·
2 min read
Business

Adaptimmune Therapeutics plc Announces Registered Direct Offering of American Depositary Shares

Adaptimmune Therapeutics plc today announced that it has entered into a definitive agreement with Matrix Capital Management Company

September 12, 2018
·
5 min read
Policy

WuXi AppTec Partner Hutchison MediPharma Receives Approval of Fruquintinib Capsules in China

WuXi AppTec congratulates its partner Hutchison MediPharma (HMP) on receiving approval of fruquintinib capsules (Elunate®) for metastatic colorectal cancer from the National Medical Products Administration of China

September 12, 2018
·
3 min read
Drug Development

Checkpoint Therapeutics Announces Encouraging Safety and Efficacy Data from Phase 1/2 Clinical Trial of EGFR Inhibitor CK-101

6 of 8 pts (75%) ORR in treatment-naïve EGFR mutation-positive NSCLC patients Well-tolerated with unremarkable safety profile; No DLTs or related SAEs

September 12, 2018
·
8 min read
Business

MR Solutions’ Founder shortlisted for the 2018 NatWest Great British Entrepreneur Awards

Founder and Chairman, Dr David Taylor, of Guildford based MR Solutions has been shortlisted as an Innovation Entrepreneur of the Year for London and the South East in the 2018 NatWest Great British Entrepreneur Awards.

September 12, 2018
·
1 min read
Job Trends

Flagship Biosciences’ Digital Tissue Image Analysis Approach Validated in Assessment of Dystrophin Muscle Biopsies; Findings Published in Archives of Pathology & Laboratory Medicine

Flagship Biosciences’ MuscleMap algorithm that supports therapeutic development for DMD, a fatal neuromuscular disease, has been validated to be as effective as manual pathology.

September 12, 2018
·
2 min read